Ovarian disease is the most deadly gynecologic danger and is the seventh driving reason for malignant growth passings in ladies around the world. Regardless of advances in medical procedure and chemotherapy, generally speaking fix rate has stayed low. The poor clinical results primarily originate from the high level of cases being analyzed at a propelled stage sickness because of the absence of viable screening strategies and successive development of chemoresistance. Ongoing confirmations have proposed that disease undeveloped cells may likewise add to the advancement of chemoresistance. In any case, there are as yet numerous inquiries on ovarian carcinogenesis and systems of chemoresistance of ovarian malignancy, which should be made plans to improve the treatment results of ovarian disease
Case Report: Cancer Science & Therapy
Case Report: Cancer Science & Therapy
Editorial: Cancer Science & Therapy
Editorial: Cancer Science & Therapy
Research Article: Cancer Science & Therapy
Research Article: Cancer Science & Therapy
Review Article: Cancer Science & Therapy
Review Article: Cancer Science & Therapy
Editorial: Cancer Science & Therapy
Editorial: Cancer Science & Therapy
Posters & Accepted Abstracts: Alternative & Integrative Medicine
Posters & Accepted Abstracts: Alternative & Integrative Medicine
Scientific Tracks Abstracts: Pulmonary & Respiratory Medicine
Scientific Tracks Abstracts: Pulmonary & Respiratory Medicine
Posters Accepted Abstracts: Cancer Science & Therapy
Posters Accepted Abstracts: Cancer Science & Therapy
Posters & Accepted Abstracts: Journal of Bioengineering & Biomedical Science
Posters & Accepted Abstracts: Journal of Bioengineering & Biomedical Science
Posters & Accepted Abstracts: Journal of Nephrology & Therapeutics
Posters & Accepted Abstracts: Journal of Nephrology & Therapeutics
Cancer Science & Therapy received 5332 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 